Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,430 public trials 1,038 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs

NCT02907359

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • City of Hope Duarte, California, United States
  • Desert Hematology Oncology Medical Group, Inc. Rancho Mirage, California, United States
  • Cancer Specialists of North Florida Fleming Island, Florida, United States
  • Mount Sinai Medical Center Miami Beach, Florida, United States
View all 112 locations
View Trial Details
Completed

SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction

NCT02348489

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • Mayo Clinic Cancer Center Scottsdale, Arizona, United States
  • Scripps Cancer Center La Jolla, California, United States
  • University of Southern California Los Angeles, California, United States
  • University of Chicago Chicago, Illinois, United States
View all 135 locations
View Trial Details
Completed

Study of ASTX727 vs IV Decitabine in Participants With MDS, CMML, and AML

NCT03306264

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • Pinnacle Research Group Anniston, Alabama, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • Compassionate Cancer Care Research Group Fountain Valley, California, United States
View all 84 locations
View Trial Details
Completed

Treatment of Hairy Cell Leukaemia Variant and Relapsing Hairy Cell Leukaemia With Cladribine Plus Rituximab

NCT02157181

Conditions
Hairy Cell Leukemia (HCL), Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • Community based hemato-oncology medical office Ansbach, Germany
  • Community based hemato-oncology medical office Aschaffenburg, Germany
  • Community based hemato-oncology medical office Celle, Germany
  • St.-Johannes-Hospital Dortmund, Germany
View all 47 locations
View Trial Details
Completed

CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies

NCT04450069

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at San Diego San Diego, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
View Trial Details
Completed

Efficacy and Safety of Tenalisib (RP6530) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

NCT04204057

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • University Multiprofile Hospital for Active Treatment "Dr Georgi Stranski" Ltd., Pleven, Bulgaria
  • University Multiprofile Hospital for Active Treatment "Sv Ivan Rilski" Ltd Sofia, Bulgaria
  • Ltd. M.Zodelava Hematology Centre Tbilisi, Georgia
  • Medivest - Institute of Hematology and Transfusiology Tbilisi, Georgia
View Trial Details

Related conditions